To support the work of the Parent's Guide to Cord Blood Foundation, click this button to make a tax deductible donation by credit card.
Scandals rock FDA
November 2004
FDA whistle-blower David J. Graham, M.D., testified before Congress that Vioxx and other approved drugs are not safe. In the fall of 2004, there has been a storm of reactions by interested parties.
- Sen Charles E. Grassley (R-Iowa) warned the agency not to retaliate against Graham.
- Sen. Bingaman (D-N.M.) says the FDA is not paying attention to its mission and suffers a "culture of collusion" with the drug industry.
- A spokesperson for PhRMA, Pharmaceutical Research and Manufacturers of America, says FDA practices are the "right way to approach safety issues".
- The American Medical Assocation, AMA, in an editorial in their journal (JAMA 1Dec2004) says that the FDA's current postmarketing surveillance system of drugs has a "lack of vigilance, lack of trust".
- The Union of Concerned Scientists is publicizing a 2002 survey by the HHS Office of the Inspector General in which FDA scientists lacked confidence in their own agency's ability to monitor drug safety.
Last modified: 21.January 2010
Copyright 2000 - 2010 Frances Verter
Copyright 2000 - 2010 Frances Verter